Soluble Fas and Fas ligand in human tear fluid after photorefractive keratectomy

被引:7
|
作者
Tuominen, I
Vesaluoma, M
Teppo, AM
Grönhagen-Riska, C
Tervo, T
机构
[1] Univ Helsinki, Hosp Eye, Eye Bank, FIN-00029 Huch, Finland
[2] Helsinki Univ Hosp, Dept Med, Helsinki, Finland
关键词
D O I
10.1136/bjo.83.12.1360
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/aims-The Fas-Fas ligand system is thought to be involved in stromal cell apoptosis after corneal wounding. The aim was to measure changes in human tear fluid levels of soluble Fas (sFas) and Fas Ligand (sFasL) following myopic photorefractive keratectomy (PRK). Methods-Tear samples of 59 patients were collected preoperatively, and 1 or 2 days after PRK. Tear fluid sFas or sFasL concentrations were determined using sandwich ELISAs. Subsequently, tear flow corrected concentrations (releases) were calculated to compensate for the postoperative tear hypersecretion. Results-The preoperative tear fluid flows (TFF) were 6.4 (1.7) mu l/min (mean (SERI)) in sFas group (n = 18), and 7.5 (1.5) mu l/min in sFasL group (n = 39). Postoperatively TFFs increased to 37.9 (10.9) mu l/min (p = 0.003) and 58.3 (7.0) mu l/min (p = 0.000), respectively. The mean preoperative sFas concentration (24.3 (11.6) U/ml) decreased to 9.7 (4.1) U/ml (p = 0.001) postoperatively, and the mean sFasL concentration (299.1 (28.8) ng/l) to 118.7 (15.9) ng/l (p = 0.000). However, the release of both substances increased significantly: sFas from 87.3 (29.4) mU/min to 229.4 (82.9) mU/min (p = 0.002) and sFasL from 1620.6 (226.4) fg/min to 4777.1 (596.1) fg/min (p = 0.000). Conclusions-Both sFas and sFasL are normal constituents of human tears. Despite a decrease in concentrations related to reflex tears, the release of sFas and sFasL increases significantly after excimer laser photorefractive keratectomy, which suggests that they are involved in corneal healing after PRK in humans.
引用
收藏
页码:1360 / 1363
页数:4
相关论文
共 50 条
  • [1] Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis
    Sugita, S
    Taguchi, C
    Takase, H
    Sagawa, K
    Sueda, J
    Fukushi, K
    Hikita, N
    Watanabe, T
    Itoh, K
    Mochizuki, M
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (10) : 1130 - 1134
  • [2] Cerebrospinal fluid soluble Fas and Fas ligand levels after aneurysmal subarachnoid haemorrhage
    Kafadar, A. M.
    Uzan, M.
    Tanriverdi, T.
    Sanus, G. Z.
    Uzun, H.
    Kaynar, M. Y.
    Kuday, C.
    [J]. CEREBRAL VASOSPASM: NEW STRATEGIES IN RESEARCH AND TREATMENT, 2008, 104 : 17 - +
  • [3] Tear fluid changes after photorefractive keratectomy
    Vesaluoma, M
    Tervo, T
    [J]. LACRIMAL GLAND, TEAR FILM, AND DRY EYE SYNDROMES 2: BASIC SCIENCE AND CLINICAL RELEVANCE, 1998, 438 : 515 - 521
  • [4] Soluble FAS (S FAS) and soluble FAS ligand (S FAS-L) in human milk.
    Srivastava, MD
    [J]. FASEB JOURNAL, 1998, 12 (05): : A797 - A797
  • [5] Serum and follicular fluid levels of soluble Fas and soluble Fas ligand in IVF cycles
    Onalan, Gogsen
    Selam, Belgin
    Onalan, Reside
    Ceyhan, Temel
    Cincik, Mehmet
    Pabuccu, Recai
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 125 (01) : 85 - 91
  • [6] Tenascin and cytokines in tear fluid after photorefractive keratectomy
    Vesaluoma, MH
    Tervo, TT
    [J]. JOURNAL OF REFRACTIVE SURGERY, 1998, 14 (04): : 447 - 454
  • [7] Plasma soluble Fas and soluble Fas ligand in chronic glomerulonephritis
    Sano, H
    Asano, K
    Minatoguchi, S
    Hiraoka, J
    Fujisawa, K
    Nishigaki, K
    Yasuda, N
    Kumada, H
    Takemura, M
    Ohashi, H
    Seishima, M
    Fujiwara, T
    Fujiwara, H
    [J]. NEPHRON, 1998, 80 (02) : 153 - 161
  • [8] SERUM SOLUBLE FAS AND SOLUBLE FAS LIGAND IN HYPERTENSION IN PREGNANCY
    Karthikeyan, Vellore J.
    Jessani, Shahirose
    Balakrishnan, Balu
    Lane, Deirdre A.
    Baghdadi, Sabah
    Beevers, D. Gareth
    Lip, Gregory Y. H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [9] Significance of Fas/Fas ligand and soluble Fas/Fas ligand system in patients with bile duct carcinoma
    Murakami, M
    Sasaki, T
    Tsuchida, A
    Kawasaki, Y
    Morinaka, K
    Fujimoto, Y
    Kariya, K
    Kuwada, Y
    Yamasaki, S
    Kuwahara, K
    Miyata, H
    Tyayama, K
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A442 - A442
  • [10] INCREASED RELEASE OF TENASCIN IN TEAR FLUID AFTER PHOTOREFRACTIVE KERATECTOMY
    VESALUOMA, M
    YLATUPA, S
    MERTANIEMI, P
    TERVO, K
    PARTANEN, P
    TERVO, T
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1995, 233 (08) : 479 - 483